Related Experiment Video
Updated: Aug 16, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 15, 2011
Amphotericin B therapy in kala-azar
1Department of Medicine, Darbhanga Medical College and Hospital, Laherisarai.
Abstract:
Twenty-seven adult patients of kala-azar unresponsive to sodium stibogluconate (SSG) were given amphotericin B in the dose schedule of 0.50 mg/kg body weight on alternate days for a total of 21 to 31 infusions, depending upon clinical and parasitological response. A 100% cure rate was achieved at the end of the therapy and no relapse was encountered during 12 months follow-up. Only mild adverse reactions were noted on the day of infusion during therapy. Amphotericin B was found to be an acceptable alternative drug for treatment of such cases.
Related Concept Videos
Fungal Phylum Microsporidia
Rocky Mountain Spotted Fever
Cryptococcal Meningitis
Antifungal Agents
Anthelminthic Agents
Antiprotozoal Agents

